Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2017-02-20
2017-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the study is to determine the incidence of unexpected difficult SBI using conventional screening tests. It is a prospective descriptive epidemiological monocentric study comparing two groups of patients (selective vs. non selective intubations).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Feasibility and Safety Study of the Use of a Dedicated Ballooned Intercostal Drain
NCT01869504
Evaluation of Patient Analgesia After Bloc Serratus
NCT04123977
Selective Lobar Blockade and Bronchial Blockers
NCT02032342
Bronchoscopy for Thoracic Trauma Patients
NCT06264856
Prospective Evaluation of Needle Exsufflation for Pneumothorax
NCT02528734
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with thoracic, cardiac, vascular or plastic surgery
Exclusion Criteria
* Patient whose age is less than 18 years
* Traditional re-intubation at the end of the procedure after a selective lung IOT;
* Selective re-intubation in a patient previously intubated on arrival at the operating theater;
* IOT in other departments of the HML (intensive care, Pulmonary Postoperative Unit (UPOP), bronchoscopy, hospitalization services, Intensive Care Unit (ICU), etc.).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Chirurgical Marie Lannelongue
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Marie Lannelongue
Le Plessis-Robinson, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A02070-51
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.